Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Etravirine: clinical review of a treatment option for HIV type-1-infected patients with non-nucleoside reverse transcriptase inhibitor resistance Towner WJ; Cassetti I; Domingo P; Nijs S; Kakuda TN; Vingerhoets J; Woodfall BAntivir Ther 2010[]; 15 (6): 803-16Despite our progressive understanding of HIV type-1 (HIV-1) infection and the development of a number of antiretroviral agents to delay the onset of AIDS, there remains a need for agents with improved efficacy and safety. In particular, therapy options for treatment-experienced adult patients have been limited by the presence of drug-resistant virus, which often leads to a reduced virological response in these patients. The recently approved non-nucleoside reverse transcriptase inhibitor etravirine has demonstrated durable and superior efficacy over placebo and a favourable tolerability profile in HIV-1-infected, treatment-experienced patients, offering a valuable new therapeutic option. This review examines the clinical development and drug profile of etravirine, placing it in the context of other antiretrovirals available for treatment-experienced patients.|Adult[MESH]|Antiretroviral Therapy, Highly Active[MESH]|Dose-Response Relationship, Drug[MESH]|Drug Resistance, Viral[MESH]|HIV Infections/*drug therapy[MESH]|HIV-1/*drug effects[MESH]|Humans[MESH]|Nitriles[MESH]|Pyridazines/*therapeutic use[MESH]|Pyrimidines[MESH]|Randomized Controlled Trials as Topic[MESH]|Reverse Transcriptase Inhibitors/*pharmacology[MESH] |